Table 7. Resistance status of patients failing LPV/r.
| B | C | non-BC | Total | p | |||
| n = 43 (18%) | n = 156 (66%) | n = 38 (16%) | n = 237 (%) | B vs.C | B vs.non-BC | C vs.non-BC | |
| Sensitive to all drugs (%) | 28 (65) | 65 (42) | 21 (55) | 114 (48) | 0.009 | 0.5 | 0.1 |
| LPV/r sensitive but resistant to backbone (%) | 5 (12) | 46 (29) | 8 (21) | 59 (28) | 0.02 | 0.4 | 0.4 |
| LPV/r sensitive (%) | 34 (79) | 111 (71) | 29 (76) | 174 (73) | 0.3 | 0.4 | 0.7 |
| LPV/r partially resistant (%) | 2 (4) | 8 (5) | 1 (4) | 11 (5) | 1 | 0.9 | 0.9 |
| LPV/r resistant (%) | 7 (16) | 37 (24) | 8 (21) | 52 (22) | 0.4 | 0.8 | 0.8 |
| Total | 43 | 156 | 38 | 237 | |||
Clinical resistance status of 237 patients failing cART including LPV/r was determined according to the True-gene™ software (version 10). The last available sample under LPV/r from each patient was used.